1.A Case of Ruptured Cryopreserved Homograft 7 Months after Implantation
Yosuke Inoue ; Ryoshi Maruyama ; Yukio Hasegawa ; Eiichiro Hata ; Akira Yamada ; Katsuhiko Nakanishi ; Keisuke Sakai
Japanese Journal of Cardiovascular Surgery 2013;42(2):128-131
Infectious abdominal aortic aneurysm is a relatively rare disease, and there is no consensus regarding its surgical treatment. Medical infectious control should be concerned comparison with surgical treatment if there is sepsis, however we sometimes have no other choice but emergency operation for uncontrollable cases. In many reports, cryopreserved homografts were used as in-situ alternative grafts for infectious aortic aneurysms because they had some merits such as anti-infectious effects, suitability and so on. However the number of in-situ cryopreserved homograft replacement cases are few, and the long term result is unclear. We encountered a ruptured cropreserved homograft case 7 months after urgent in-situ cryopreserved homograft replacement. We report the case and refer to the relevans literature.
2.Live trauma surgery demonstration with a porcine model is valuable training for physicians and nurses
Yoshimitsu Izawa ; Yasumitsu Mizobata ; Takashi Fujita ; Hisashi Matsumoto ; Michiaki Hata ; Chikara Yonekawa ; Takashi Nagata ; Shuji Hishikawa ; Yukitoshi Makimura ; Satoshi Kunita ; Keisuke Yamashita ; Masayuki Suzukawa ; Alan K. Lefor
Medical Education 2015;46(6):497-502
Sources of research funding: We gratefully acknowledge the support of the 17th Congress of the Japanese Society for Emergency Medicine support of this program.
Ethical considerations: The program was conducted after receiving approval from the Institutional Animal Experiment Committee of the Jichi Medical University, and in accordance with the Institutional Regulation for Animal Experiments and Fundamental Guideline for Proper Conduction of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology of Japan. It was approved on April 9th, 2014. The approval number is 14-225.
Disclosure of conflicts of interests: We gratefully acknowledge the contributions of personnel from Panasonic Corp. who enabled the interactive communication system.
Abstract
Introduction: Live surgery demonstrations have been widely used in surgical education. However, they cannot be used to demonstrate trauma surgery due to the emergency situation and lack of informed consent. The aim of this study was to conduct a live demonstration of trauma surgery with a porcine model to increase educational opportunities in trauma surgery.
Methods: Live demonstration was conducted at the Center for Development of Advanced Medical Technology (CDAMtec) , Jichi Medical University, Japan. An experienced trauma surgeon instructed three trainees during a live demonstration using pre-planned injuries in a porcine model. A six-point Likert Scale was used on a written survey to determine the value of the program to the viewers. Free-form written comments were also obtained from the participants. Live images of the surgical field were transmitted to a lecture room by a closed wireless LAN with interactive bidirectional audio capability.
Results: Eighty-three participants viewed this live demonstration and completed the questionnaire. Participants were highly satisfied with the live demonstration (mean survey scores: 4.6-5.1/6) , and gave very positive feedback concerning the educational value of this program. Nine free-form comments were submitted, which revealed that the participants felt they could acquire concrete skills for trauma surgery.
Discussion: Live demonstrations for trauma surgery using a porcine model are a feasible and effective educational tool to demonstrate technical procedures and non-technical skills, with possible added advantages regarding the ethical considerations of performing a live surgery demonstration.
3.Risk factors for non-reaching of ileal pouch to the anus in laparoscopic restorative proctocolectomy with handsewn anastomosis for ulcerative colitis
Shigenobu EMOTO ; Keisuke HATA ; Hiroaki NOZAWA ; Kazushige KAWAI ; Toshiaki TANAKA ; Takeshi NISHIKAWA ; Yasutaka SHUNO ; Kazuhito SASAKI ; Manabu KANEKO ; Koji MURONO ; Yuuki IIDA ; Hiroaki ISHII ; Yuichiro YOKOYAMA ; Hiroyuki ANZAI ; Hirofumi SONODA ; Soichiro ISHIHARA
Intestinal Research 2022;20(3):313-320
Background/Aims:
Restorative proctocolectomy (RPC) with ileal pouch-anal anastomosis and handsewn anastomosis for ulcerative colitis requires pulling down of the ileal pouch into the pelvis, which can be technically challenging. We examined risk factors for the pouch not reaching the anus.
Methods:
Clinical records of 62 consecutive patients who were scheduled to undergo RPC with handsewn anastomosis at the University of Tokyo Hospital during 1989–2019 were reviewed. Risk factors for non-reaching were analyzed in patients in whom hand sewing was abandoned for stapled anastomosis because of nonreaching. Risk factors for non-reaching in laparoscopic RPC were separately analyzed. Anatomical indicators obtained from presurgical computed tomography (CT) were also evaluated.
Results:
Thirty-seven of 62 cases underwent laparoscopic procedures. In 6 cases (9.7%), handsewn anastomosis was changed to stapled anastomosis because of non-reaching. Male sex and a laparoscopic approach were independent risk factors of non-reaching. Distance between the terminal of the superior mesenteric artery (SMA) ileal branch and the anus > 11 cm was a risk factor for non-reaching.
Conclusions
Laparoscopic RPC with handsewn anastomosis may limit extension and induction of the ileal pouch into the anus. Preoperative CT measurement from the terminal SMA to the anus may be useful for predicting non-reaching.
4.Perianal and Vulvar Extramammary Paget Disease: A Report of Six Cases and Mapping Biopsy of the Anal Canal.
Yuzo NAGAI ; Sinsuke KAZAMA ; Daisuke YAMADA ; Takuya MIYAGAWA ; Koji MURONO ; Koji YASUDA ; Takeshi NISHIKAWA ; Toshiaki TANAKA ; Tomomichi KIYOMATSU ; Keisuke HATA ; Kazushige KAWAI ; Yuri MASUI ; Hiroaki NOZAWA ; Hironori YAMAGUCHI ; Soichiro ISHIHARA ; Takafumi KADONO ; Toshiaki WATANABE
Annals of Dermatology 2016;28(5):624-628
Treatment of perianal and vulvar extramammary Paget disease (EMPD), rare intraepithelial malignancies, is often challenging because of its potential to spread into the anal canal. However, there is still no consensus regarding the optimal resection margin within the anal canal. Between 2004 and 2014, six patients (three with perianal EMPD and three with vulvar EMPD) in which the spread of Paget cells into the anal canal was highly suspected were referred to our department. To evaluate the disease extent within the anal canal, preoperative mapping biopsy of the anal canal was performed in five out of six patients. Two patients were positive for Paget cells within the anal canal (one at the dentate line and the other at 0.5 cm above the dentate line), whereas in three patients, Paget cell were present only in the skin of the anal verge. Using 1 cm margin within the anal canal from the positive biopsy sites, we performed anal-preserving wide local excision (WLE), and negative resection margins within the anal canal were confirmed in all five patients. The remaining one patient with perianal EMPD did not undergo mapping biopsy of the anal canal because preoperative colonoscopy revealed that the Paget cells had spread into the lower rectum. Therefore, WLE with abdominoperineal resection was performed. During the median follow-up period of 37.3 months, no local recurrence was observed in all patients. Our small case series suggest the usefulness of mapping biopsy of the anal canal for the treatment of perianal and vulvar EMPD.
Anal Canal*
;
Biopsy*
;
Colonoscopy
;
Consensus
;
Follow-Up Studies
;
Humans
;
Paget Disease, Extramammary*
;
Rectum
;
Recurrence
;
Skin
5.Perianal and Vulvar Extramammary Paget Disease: A Report of Six Cases and Mapping Biopsy of the Anal Canal.
Yuzo NAGAI ; Sinsuke KAZAMA ; Daisuke YAMADA ; Takuya MIYAGAWA ; Koji MURONO ; Koji YASUDA ; Takeshi NISHIKAWA ; Toshiaki TANAKA ; Tomomichi KIYOMATSU ; Keisuke HATA ; Kazushige KAWAI ; Yuri MASUI ; Hiroaki NOZAWA ; Hironori YAMAGUCHI ; Soichiro ISHIHARA ; Takafumi KADONO ; Toshiaki WATANABE
Annals of Dermatology 2016;28(5):624-628
Treatment of perianal and vulvar extramammary Paget disease (EMPD), rare intraepithelial malignancies, is often challenging because of its potential to spread into the anal canal. However, there is still no consensus regarding the optimal resection margin within the anal canal. Between 2004 and 2014, six patients (three with perianal EMPD and three with vulvar EMPD) in which the spread of Paget cells into the anal canal was highly suspected were referred to our department. To evaluate the disease extent within the anal canal, preoperative mapping biopsy of the anal canal was performed in five out of six patients. Two patients were positive for Paget cells within the anal canal (one at the dentate line and the other at 0.5 cm above the dentate line), whereas in three patients, Paget cell were present only in the skin of the anal verge. Using 1 cm margin within the anal canal from the positive biopsy sites, we performed anal-preserving wide local excision (WLE), and negative resection margins within the anal canal were confirmed in all five patients. The remaining one patient with perianal EMPD did not undergo mapping biopsy of the anal canal because preoperative colonoscopy revealed that the Paget cells had spread into the lower rectum. Therefore, WLE with abdominoperineal resection was performed. During the median follow-up period of 37.3 months, no local recurrence was observed in all patients. Our small case series suggest the usefulness of mapping biopsy of the anal canal for the treatment of perianal and vulvar EMPD.
Anal Canal*
;
Biopsy*
;
Colonoscopy
;
Consensus
;
Follow-Up Studies
;
Humans
;
Paget Disease, Extramammary*
;
Rectum
;
Recurrence
;
Skin
6.Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Keisuke YAMASAKI ; Jun HATA ; Tomomi IDE ; Takuya NAGATA ; Satoko SAKATA ; Daigo YOSHIDA ; Takanori HONDA ; Yoichiro HIRAKAWA ; Toshiaki NAKANO ; Takanari KITAZONO ; Hiroyuki TSUTSUI ; Toshiharu NINOMIYA
Environmental Health and Preventive Medicine 2021;26(1):47-47
BACKGROUND:
Epidemiological evidence has shown that serum N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations, a diagnostic biomarker for heart failure, are positively associated with cardiovascular risk. Since NT-proBNP in serum is excreted in urine, it is hypothesized that urinary NT-proBNP concentrations are correlated with serum concentrations and linked with cardiovascular risk in the general population.
METHODS:
A total of 3060 community-dwelling residents aged ≥ 40 years without history of cardiovascular disease (CVD) were followed up for a median of 8.3 years (2007-2015). Serum and urinary concentrations of NT-proBNP at baseline were compared. The hazard ratios (HRs) and their 95% confidence intervals (CIs) for the association between NT-proBNP concentrations and the risk of developing CVD were computed using the Cox proportional hazards model.
RESULTS:
The median values (interquartile ranges) of serum and urinary NT-proBNP concentrations at baseline were 56 (32-104) pg/mL and 20 (18-25) pg/mL, respectively. There was a strong quadratic correlation between the serum and urinary concentrations of NT-proBNP (coefficient of determination [R
CONCLUSIONS
The present study demonstrated that urinary NT-proBNP concentrations were well-correlated with serum concentrations and were positively associated with cardiovascular risk. Given that urine sampling is noninvasive and does not require specially trained personnel, urinary NT-proBNP concentrations have the potential to be an easy and useful biomarker for detecting people at higher cardiovascular risk.
Adult
;
Aged
;
Aged, 80 and over
;
Biomarkers/urine*
;
Cardiovascular Diseases/urine*
;
Female
;
Heart Failure/diagnosis*
;
Humans
;
Incidence
;
Japan/epidemiology*
;
Male
;
Middle Aged
;
Natriuretic Peptide, Brain/urine*
;
Peptide Fragments/urine*
;
Prospective Studies
;
Risk Assessment